Inventor · disambiguated record
Michael E. Jung
Also filed as: JUNG MICHAEL · JUNG MICHAEL E · JUNG MICHAEL ELLIOT
83 granted patents·51 pending applications·843 citations·filing 1990–2025
99Inventor score
Files withUNIV CALIFORNIA82JUNG MICHAEL E7ARBUTUS BIOPHARMA CORP6MANOHARAN MUTHIAH5PHILLIPS PETROLEUM CO5
Top patents by PatentIndex Score
134 records- 0198US8883202B2Lipid compositionsMANOHARAN MUTHIAH·Filed 2010·Granted Nov 11, 2014·104 cites·22 claims
- 0298US7709517B2Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2006·Granted May 4, 2010·99 cites·13 claims
- 0397US8445507B2Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseasesJUNG MICHAEL E·Filed 2007·Granted May 21, 2013·73 cites·31 claims
- 0496US11787804B2Compositions and methods for modulating hair growthUNIV CALIFORNIA·Filed 2022·Granted Oct 17, 2023·2 cites·13 claims
- 0596US11472804B2Compositions and methods for modulating hair growthUNIV CALIFORNIA·Filed 2022·Granted Oct 18, 2022·4 cites·3 claims
- 0696US8183274B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2010·Granted May 22, 2012·42 cites·40 claims
- 0795US12227503B2Compositions and methods for modulating hair growthUNIV CALIFORNIA·Filed 2023·Granted Feb 18, 2025·1 cites·13 claims
- 0895US9126941B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2012·Granted Sep 8, 2015·26 cites·32 claims
- 0995US8802689B2Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseasesJUNG MICHAEL E·Filed 2012·Granted Aug 12, 2014·25 cites·19 claims
- 1094US9987261B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2016·Granted Jun 5, 2018·12 cites·21 claims
- 1193US9388159B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2014·Granted Jul 12, 2016·15 cites·33 claims
- 1293US8110594B2Diarylthiohydantoin compoundsJUNG MICHAEL E·Filed 2007·Granted Feb 7, 2012·26 cites·51 claims
- 1392US11312714B2Compositions and methods for modulating hair growthUNIV CALIFORNIA·Filed 2018·Granted Apr 26, 2022·3 cites·3 claims
- 1492US10857139B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2018·Granted Dec 8, 2020·4 cites·15 claims
- 1592US7718684B2Methods and materials for assessing prostate cancer therapies and compoundsUNIV CALIFORNIA·Filed 2005·Granted May 18, 2010·13 cites·13 claims
- 1691US9566340B2Monomers and oligonucleotides comprising cycloaddition adduct(s)ALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·11 cites·12 claims
- 1791US8648105B2Diarylthiohydantoin compoundsJUNG MICHAEL E·Filed 2011·Granted Feb 11, 2014·18 cites·27 claims
- 1891US8022052B2Inhibition of PPAR gamma expression by specific osteogenic oxysterolsUNIV CALIFORNIA·Filed 2007·Granted Sep 20, 2011·28 cites·19 claims
- 1990US10456473B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Oct 29, 2019·6 cites·8 claims
- 2088US5886202ABridged fluorenyl/indenyl metallocenes and the use thereofFiled 1997·Granted Mar 23, 1999·61 cites·36 claims
- 2187US10953095B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2019·Granted Mar 23, 2021·1 cites·19 claims
- 2287US9198972B2Monomers and oligonucleotides comprising cycloaddition adduct(s)MANOHARAN MUTHIAH·Filed 2011·Granted Dec 1, 2015·10 cites·8 claims
- 2387US7652134B2Methods for converting quinolone esters into quinolone amidesCYLENE PHARMACEUTICALS INC·Filed 2005·Granted Jan 26, 2010·11 cites·29 claims
- 2487US7262268B2Lipopeptide stereoisomers, methods for preparing same, and useful intermediatesCUBIST PHARM INC·Filed 2002·Granted Aug 28, 2007·13 cites·7 claims
- 2587US5252538A(2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for the preparation of and use of said compounds as herbicidal agentsAMERICAN CYANAMID CO·Filed 1990·Granted Oct 12, 1993·18 cites·27 claims
- 2687US2024293383A1Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2786US12023383B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2023·Granted Jul 2, 2024·0 cites·20 claims
- 2886US2024132452A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2984US11708329B2Inhibitors of the WNT/beta-catenin pathwayUNIV CALIFORNIA·Filed 2019·Granted Jul 25, 2023·2 cites·19 claims
- 3084US11377451B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2021·Granted Jul 5, 2022·2 cites·22 claims
- 3182US9694077B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2014·Granted Jul 4, 2017·3 cites·13 claims
- 3282US2023109968A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3381US7335726B2Lipopeptide stereoisomers, methods for preparing same and useful intermediatesCUBIST PHARM INC·Filed 2006·Granted Feb 26, 2008·4 cites·3 claims
- 3480US5726264AProcesses to produce metallocene compounds and polymerization processes therewithPHILLIPS PETROLEUM CO·Filed 1996·Granted Mar 10, 1998·24 cites·10 claims
- 3579US9717742B2Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesisUNIV CALIFORNIA·Filed 2013·Granted Aug 1, 2017·4 cites·11 claims
- 3678US11059817B2Potent antiviral pyrazolopyridine compoundsUNIV CALIFORNIA·Filed 2016·Granted Jul 13, 2021·2 cites·20 claims
- 3778US2025333385A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 3877US9266901B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2014·Granted Feb 23, 2016·1 cites·3 claims
- 3977US9045474B2Compounds and compositions for mitigating tissue damage and lethalitySCHIESTL ROBERT H·Filed 2011·Granted Jun 2, 2015·7 cites·12 claims
- 4076US12404243B2Inhibitors of the Wnt/beta-catenin pathwayUNIV CALIFORNIA·Filed 2023·Granted Sep 2, 2025·0 cites·16 claims
- 4176US9255088B2Premature-termination-codons readthrough compoundsUNIV CALIFORNIA·Filed 2013·Granted Feb 9, 2016·2 cites·6 claims
- 4276US2025304579A1Compositions and methods for modulating hair growthUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 4375US11771687B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2020·Granted Oct 3, 2023·0 cites·28 claims
- 4475US10980767B2Estrogen receptor ligands, compositions and methods related theretoUNIV CALIFORNIA·Filed 2017·Granted Apr 20, 2021·1 cites·19 claims
- 4575US9981961B2Deoxycytidine kinase inhibitorsUNIV CALIFORNIA·Filed 2017·Granted May 29, 2018·2 cites·23 claims
- 4675US9598404B2Deoxycytidine kinase inhibitorsUNIV CALIFORNIA·Filed 2016·Granted Mar 21, 2017·2 cites·19 claims
- 4775US2021238145A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4875US2022040308A1Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 4972US11180498B2Substituted pyrrolo[2,3-b]pyridines, pyrazolo[3,4-d]pyrimidines and [1,2,3]triazolo[4,5-b]pyridines as potent antiviralsUNIV CALIFORNIA·Filed 2018·Granted Nov 23, 2021·2 cites·21 claims
- 5072US5854363A(Omega-alkenyl) (cyclopentacarbyl) metallocene compoundsPHILLIPS PETROLEUM CO·Filed 1997·Granted Dec 29, 1998·41 cites·40 claims
Showing the top 50 of 134 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael E. Jung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →